- Home
- / Targeted Medical Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Targeted Medical Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$323 K
2024-10-29
Revenue
$5.3 M
FY, 2015
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 |
|---|---|---|---|---|---|
| Revenue | 8.8M | 7.3M | 9.6M | 7.1M | 5.3M |
| Cost of goods sold | 2.8M | 3.2M | 3.0M | 2.2M | 2.1M |
| Gross profit | 6.1M | 4.1M | 6.6M | 4.9M | 3.2M |
| Gross profit margin, % | 68.7% | 56.1% | 68.7% | 68.8% | 60.2% |
| General and administrative expense | 11.7M | 10.1M | 10.2M | 7.3M | 5.2M |
| Operating expense total | 11.8M | 10.2M | 10.4M | 7.5M | 5.2M |
| EBIT | (5.8M) | (6.1M) | (3.8M) | (2.6M) | (2.0M) |
| EBIT margin, % | -65.6% | -84.1% | -40.2% | -36.7% | -38.6% |
| Investment income | 7.6K | ||||
| Interest expense | 875.8K | 2.2M | 1.2M | ||
| Pre tax profit | (6.6M) | (12.8M) | (3.7M) | (3.8M) | (3.1M) |
| Income tax expense | (2.5M) | (3.2M) | 5.7M | 65.8K | |
| Net Income | (4.2M) | (9.6M) | (9.3M) | (3.9M) | (3.1M) |